Identification of a novel LPL gene mutation (LPLobama) provides a rapid screening method for subjects with type IV and type I hyperlipoproteinemia.
No takes yet. Share an insight, caveat, or question.
May support genetic screening in type I/IV hyperlipoproteinemia; leaves open validation in larger cohorts before clinical adoption.
Takagi et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: